K. Ranade

729 total citations
20 papers, 484 citations indexed

About

K. Ranade is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, K. Ranade has authored 20 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in K. Ranade's work include Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers) and Bacteriophages and microbial interactions (2 papers). K. Ranade is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Cancer Genomics and Diagnostics (3 papers) and Bacteriophages and microbial interactions (2 papers). K. Ranade collaborates with scholars based in United States, Spain and United Kingdom. K. Ranade's co-authors include Anthony R. Poteete, Brandon W. Higgs, Katie Streicher, Michael Howell, Tomas Mustelin, Philip Z. Brohawn, Zhenna Xiao, Kim Lehmann, Rosa A. Carrasco and Robert W. Georgantas and has published in prestigious journals such as Genes & Development, Oncogene and Journal of Bacteriology.

In The Last Decade

K. Ranade

20 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Ranade United States 12 221 109 81 74 66 20 484
Jia‐Ping Wu Taiwan 13 310 1.4× 101 0.9× 64 0.8× 17 0.2× 72 1.1× 29 556
Xiaobo Chen China 9 308 1.4× 47 0.4× 76 0.9× 61 0.8× 43 0.7× 32 594
M Granzow Germany 12 182 0.8× 45 0.4× 38 0.5× 60 0.8× 32 0.5× 13 760
Yujuan Qi China 12 188 0.9× 82 0.8× 47 0.6× 34 0.5× 56 0.8× 47 395
Dizhe Eb Russia 14 392 1.8× 90 0.8× 139 1.7× 51 0.7× 43 0.7× 39 596
Martin Majer United States 11 292 1.3× 45 0.4× 47 0.6× 47 0.6× 64 1.0× 20 666
Rasheeba Nizam Kuwait 14 193 0.9× 55 0.5× 95 1.2× 44 0.6× 20 0.3× 47 497
Joseph Maranville United States 11 166 0.8× 75 0.7× 97 1.2× 35 0.5× 33 0.5× 20 412
Roshni Srivastava United States 9 176 0.8× 42 0.4× 39 0.5× 39 0.5× 12 0.2× 12 331
Jinghua Du China 13 312 1.4× 239 2.2× 21 0.3× 51 0.7× 49 0.7× 21 679

Countries citing papers authored by K. Ranade

Since Specialization
Citations

This map shows the geographic impact of K. Ranade's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Ranade with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Ranade more than expected).

Fields of papers citing papers by K. Ranade

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Ranade. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Ranade. The network helps show where K. Ranade may publish in the future.

Co-authorship network of co-authors of K. Ranade

This figure shows the co-authorship network connecting the top 25 collaborators of K. Ranade. A scholar is included among the top collaborators of K. Ranade based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Ranade. K. Ranade is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamid, Omid, Laura Collins, Marcus O. Butler, et al.. (2024). 66O Association of a blood T cell fitness gene signature with clinical benefit from ImmTAC bispecific T cell engagers. Annals of Oncology. 35. S239–S240. 1 indexed citations
2.
Rodriguez, J.M. Piulats, Agatha Treveil, Paula Nieto, et al.. (2023). 2238P Tebentafusp reprograms immunosuppressive tumor-associated M2 macrophages towards anti-tumoral M1 macrophages. Annals of Oncology. 34. S1152–S1153. 1 indexed citations
3.
Cruz‐Merino, Luis de la, Zeynep Eroglu, Linda Collins, et al.. (2021). 1770P Genomic correlates of clinical outcomes in patients with metastatic uveal melanoma (mUM) treated with tebentafusp (tebe). Annals of Oncology. 32. S1214–S1215. 2 indexed citations
4.
Shoushtari, Alexander N., Laura Collins, Enrique Espinosa, et al.. (2021). 1757O Early reduction in ctDNA, regardless of best RECIST response, is associated with overall survival (OS) on tebentafusp in previously treated metastatic uveal melanoma (mUM) patients. Annals of Oncology. 32. S1210–S1210. 17 indexed citations
5.
6.
7.
Higgs, Brandon W., et al.. (2018). AB1212 Analytical validation of an interferon-inducible gene expression kit as a potential diagnostic test for anifrolumab. Annals of the Rheumatic Diseases. 77. 1704–1705. 1 indexed citations
8.
Si, Han, Brandon W. Higgs, Philip Z. Brohawn, et al.. (2018). Somatic mutations in BRCA2, NFE2L2, ARID1A and NOTCH1 sensitize to anti-PDL1 therapy in multiple tumor types. Annals of Oncology. 29. x1–x1. 4 indexed citations
9.
Higgs, Brandon W., Chris Morehouse, Srikala S. Sridhar, et al.. (2018). High tumor mutational burden (TMB) and PD-L1 have similar predictive utility in 2L+ NSCLC patients (pts) treated with anti-PD-L1 and anti-CTLA-4. Annals of Oncology. 29. viii19–viii19. 3 indexed citations
10.
Howell, Michael, et al.. (2015). Past, present, and future for biologic intervention in atopic dermatitis. Allergy. 70(8). 887–896. 39 indexed citations
11.
Higgs, Brandon W., Paul B. Robbins, John A. Blake-Haskins, et al.. (2015). 15LBA High tumoral IFNγ mRNA, PD-L1 protein, and combined IFNγ mRNA/PD-L1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patients. European Journal of Cancer. 51. S717–S717. 29 indexed citations
12.
Streicher, Katie, Chris Morehouse, Bhargavi Rajan, et al.. (2013). THU0005 Investigating the Plasma Cell Signature in Autoimmune Disease. Annals of the Rheumatic Diseases. 72. A166–A166. 2 indexed citations
13.
Streicher, Katie, Wei Zhu, Kim Lehmann, et al.. (2011). A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth. Oncogene. 31(12). 1558–1570. 110 indexed citations
14.
Ranade, K.. (2003). a genome scan for hypertension susceptibility loci in populations of Chinese and Japanese origins. American Journal of Hypertension. 16(2). 158–162. 44 indexed citations
15.
16.
Ranade, K.. (2001). Genetic variation in the human urea transporter-2 is associated with variation in blood pressure. Human Molecular Genetics. 10(19). 2157–2164. 40 indexed citations
17.
Ranade, K., Kwan‐Dun Wu, M.-S. Chang, et al.. (2000). Lack of evidence for an association between  -adducin and blood pressure regulation in Asian populations. American Journal of Hypertension. 13(6). 704–709. 46 indexed citations
18.
Levran, Orna, Leonid Kruglyak, K. Ranade, et al.. (1996). A locus for Fanconi anemia on 16q determined by homozygosity mapping.. PubMed. 59(2). 377–84. 24 indexed citations
19.
Ranade, K. & Anthony R. Poteete. (1993). A switch in translation mediated by an antisense RNA.. Genes & Development. 7(8). 1498–1507. 18 indexed citations
20.
Ranade, K. & Anthony R. Poteete. (1993). Superinfection exclusion (sieB) genes of bacteriophages P22 and lambda. Journal of Bacteriology. 175(15). 4712–4718. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia‐Ping Wu Breakdown of academic impact, for papers by Xiaobo Chen Breakdown of academic impact, for papers by M Granzow Breakdown of academic impact, for papers by Yujuan Qi Breakdown of academic impact, for papers by Dizhe Eb Breakdown of academic impact, for papers by Martin Majer Breakdown of academic impact, for papers by Rasheeba Nizam Breakdown of academic impact, for papers by Joseph Maranville Breakdown of academic impact, for papers by Roshni Srivastava Breakdown of academic impact, for papers by Jinghua Du
Rankless by CCL
2026